After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...